文献速递神经MR

多发性硬化铁环病灶的特征:疾病活动与进展的生物标志物——系统综述与荟萃分析

Characterizing iron rim lesions in multiple sclerosis: a biomarker for disease activity and progression: a systematic review and meta-analysis.
PubMed 文献 · Neuroradiology · 2025-07-21

该研究系统检索PubMed、Scopus、Web of Science和Google Scholar(截至2024年6月10日),纳入13项研究、共924例多发性硬化患者,评估铁环病灶的预后价值。结果显示铁环阳性患者EDSS评分更高、白质病变更大、脑体积更小,但复发率与治疗反应无显著差异。

要点

  • 铁环阳性患者EDSS评分更高(SMD 0.77,95%CI 0.34-1.21,p=0.000),提示更严重的功能障碍。
  • 铁环阳性患者白质病灶负荷更大(SMD 0.52,95%CI 0.01-1.03,p=0.000),脑体积更小(SMD -0.50,95%CI -0.82至-0.19,p=0.015)。
  • 铁环阳性患者接受高剂量疾病修饰治疗者结局有改善趋势(RR 1.2,95%CI 0.94-1.52,p=0.424),但未达统计学显著。

核心结论

  • 铁环病灶与多发性硬化患者更高的疾病严重程度、病灶负荷及神经变性密切相关,作者认为应考虑将其纳入常规医学评估,因其是可靠的预后指标。
  • 作者认为对铁环阳性患者早期使用高剂量治疗可能带来潜在获益,但需进一步研究以确定长期临床意义。

研究设计与样本

  • 系统综述与荟萃分析,纳入13项研究、共924例多发性硬化患者,检索PubMed、Scopus、Web of Science和Google Scholar至2024年6月10日。
  • 纳入标准为采用先进MRI技术、特别是磁敏感加权成像(SWI)检出铁环病灶的多发性硬化患者研究。
  • 连续变量采用标准化均数差(SMD)计算效应量,二分类结局采用相对危险度(RR)。

关键影像表现/征象

  • 铁环病灶以磁敏感加权成像(SWI)检出,原文未进一步描述其信号或形态学特征。
  • 铁环阳性个体较铁环阴性者EDSS评分更高,白质病灶负荷更大,脑体积更小。

诊断标准与关键数值

  • EDSS评分:铁环阳性 vs 阴性 SMD 0.77(95%CI 0.34-1.21,p=0.000)。
  • 白质病灶负荷:铁环阳性 vs 阴性 SMD 0.52(95%CI 0.01-1.03,p=0.000)。
  • 脑体积:铁环阳性 vs 阴性 SMD -0.50(95%CI -0.82至-0.19,p=0.015)。
  • 复发率比:1.10(95%CI 0.73-1.65,p=0.499),未达统计学显著。
  • 疾病修饰治疗反应:RR 0.97(95%CI 0.89-1.06,p=0.424);接受高剂量疾病修饰治疗的铁环阳性患者RR 1.2(95%CI 0.94-1.52,p=0.424)。

临床应用与阅片要点

  • 作者认为铁环病灶是可靠的预后指标,应考虑将其纳入常规医学评估。
  • 作者认为对铁环阳性患者早期使用高剂量治疗可能带来潜在获益,但需进一步研究确定长期临床意义。

局限性

  • 原文结论指出,需进一步研究以确定铁环病灶的长期临床意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Iron rim lesions (IRLs) have emerged as important biomarkers in multiple sclerosis (MS), indicating chronic active inflammation and neurodegeneration. The purpose of this systematic review and meta-analysis is to assess the prognostic value of IRLs in MS, their impact on clinical outcomes, and their relationship with therapeutic responses.

METHODS: A thorough search was conducted across PubMed, Scopus, Web of Science, and Google Scholar, covering studies published until June 10, 2024. The inclusion criteria included studies on MS patients who had IRLs detected using advanced MRI techniques, particularly susceptibility-weighted imaging (SWI). The meta-analysis included 13 studies and a total of 924 MS patients. The data on clinical outcomes (EDSS scores, relapse rates), brain volume, and white matter lesion (WML) burden were combined. For continuous variables, effect sizes were calculated using standardized mean differences (SMDs), and for binary outcomes, relative risks (RRs).

RESULTS: This meta-analysis indicated significant correlations between IRLs and poorer clinical outcomes. IRL-positive individuals had higher EDSS scores (SMD 0.77, 95% CI: 0.34-1.21, p = 0.000), indicating a more severe impairment. They also had a larger WML load (SMD 0.52, 95% CI: 0.01-1.03, p = 0.000) and a smaller brain volume (SMD -0.50, 95% CI -0.82 to -0.19, p = 0.015). The relapse rate ratio was 1.10 (95% CI 0.73-1.65, p = 0.499), indicating a trend toward more frequent relapses in IRL-positive patients, though not statistically significant. Treatment response to disease-modifying treatments (DMTs) was similar in IRL-positive and negative individuals (RR 0.97, 95% CI: 0.89-1.06, p = 0.424). However, IRL-positive patients who received high-dose DMTs (HDMT) had a trend toward better outcomes (RR 1.2, 95% CI 0.94-1.52, p = 0.424).

CONCLUSIONS: IRLs are strongly linked to higher disease severity, lesion burden, and neurodegeneration in MS patients. These lesions should be considered in routine medical evaluations since they are reliable prognostic indicators. Early intervention with high-dose treatment might offer potential benefits for IRL-positive patients, but further research is needed to determine the long-term clinical implications.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Motamedgorji N, Bahrami A, Taher HJ, et al. Characterizing iron rim lesions in multiple sclerosis: a biomarker for disease activity and progression: a systematic review and meta-analysis. Neuroradiology. 2025. PMID: 40689996. doi:10.1007/s00234-025-03663-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。